Developer docs
API playgroundTry for free, no card

Search company profiles

Satisfai Health

Full company profile

uuid0008eka

Namestring
Satisfai Health
Legal namestring
Dova Health Intelligence Inc.
Websiteurl
satisfai.health
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Dova Health Intelligence (formerly Satisfai Health) is a Vancouver-based medical AI company developing computer-vision and deep-learning software for gastrointestinal disease assessment. The company builds three product lines — DovaVision UC for ulcerative colitis endoscopic severity scoring from colonoscopy videos, DovaVision BE for Barrett's Esophagus surveillance and early esophageal adenocarcinoma detection, and DovaSound for intestinal ultrasound analysis in inflammatory bowel disease — all delivered via a cloud-based API/SaaS platform with three-layered (video/frame/pixel) explainable outputs and embedded quality control. DovaVision BE holds FDA Breakthrough Device Designation (December 2023), and the company is pursuing FDA clearance for DovaVision UC in collaboration with Mayo Clinic. Its proprietary models are trained on 108 million annotated endoscopy frames and validated at 0.867 QWK and 0.869 ICC against expert central reading.

The company earns revenue through subscription-based B2B SaaS contracts for clinical trial imaging analysis, anchored by an exclusive channel partnership with Alimentiv (a GI-specialized CRO) that makes DovaVision UC commercially available on the Notō imaging platform for Phase I-IV ulcerative colitis trials. Additional revenue streams under development include FDA-cleared medical device sales for clinical practice (DovaVision BE, DovaVision UC post-clearance, and DovaSound) and enterprise licensing to pharmaceutical sponsors and academic medical centers. The customer base spans pharmaceutical/biotech trial sponsors (primary), CROs such as Alimentiv (primary), healthcare providers, and academic research institutions including Oxford, Calgary, NYU, Indiana, and UCI. To date the company has disclosed CAD $2 million in non-dilutive grant funding from Canada's DIGITAL Supercluster and acquired Docbot in November 2022; no institutional venture financing has been publicly disclosed.

Short descriptiontext

Dova Health Intelligence (formerly Satisfai Health) develops AI-powered computer-vision software for gastrointestinal disease assessment, with DovaVision UC, DovaVision BE, and DovaSound serving pharmaceutical clinical trial sponsors, CROs, and gastroenterology providers through a SaaS/API platform.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
gastrointestinal AI software, endoscopy image analysis, medical imaging AI, ulcerative colitis diagnostics, intestinal ultrasound analysis
Industry3 codes
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)
NAICS code1 code
  • Software Publishers513210
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Imaging AI Software
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Clinical Trial Services - DovaVision UC
TypeSubscription Recurring
Description

AI-powered endoscopy analysis provided to pharmaceutical companies and CROs for clinical trial endpoints. Currently available for research and clinical trials through Alimentiv partnership. B2B enterprise licensing model.

satisfai.health
2SaaS Platform - API-Based Analysis
TypeSubscription Recurring
Description

Cloud-based SaaS application for video analysis delivered via secure API integration. Subscription-based model for clinical sites, research institutions, and enterprise deployments.

satisfai.health
3Medical Device Development
TypeSubscription Recurring
Description

DovaVision BE and DovaSound in development for clinical practice. Future revenue from FDA-cleared medical devices for hospital and clinical deployment.

satisfai.health
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 3 records shown
1DovaVision UC
Description

AI-powered dynamic frame-level Mayo Endoscopic Sub-score feature analysis solution for endoscopy videos in ulcerative colitis clinical trials.

satisfai.health
+2 more records
Core offering1 text field

Satisfai Health, now operating as Dova Health Intelligence, develops AI-powered computer vision software that analyzes gastrointestinal medical imaging (colonoscopy, gastroscopy, and intestinal ultrasound videos) to deliver quantitative disease severity scoring for ulcerative colitis, Barrett's Esophagus, and inflammatory bowel disease. The products are delivered as cloud-based SaaS with API integration for clinical trials, pharmaceutical research, and future clinical practice.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 0.867 Quadratic Weighted Kappa (QWK) for video-level MES scoring
+2 more records
Product overview1 text field

Dova Health Intelligence (formerly Satisfai Health) operates as a unified AI-powered platform with three core products targeting gastrointestinal care and clinical research. The product portfolio centers on DovaVision UC for ulcerative colitis endoscopic analysis, DovaVision BE for Barrett's Esophagus detection, and DovaSound for intestinal ultrasound IBD assessment. All products share a common AI infrastructure built on deep learning models trained on millions of expertly annotated medical images, delivered via secure cloud-based SaaS with embedded quality assurance and API-based integration capabilities. The platform serves both pharmaceutical companies conducting clinical trials and healthcare providers delivering patient care.

Product and service3 records
1DovaVision UC
CategoryAI Endoscopy Analysis Software
Description

AI-powered endoscopy analysis platform providing frame-level quantitative assessments and standardized MES and UCEIS scoring outputs from colonoscopy videos for ulcerative colitis clinical trials and research.

2DovaVision BE
CategoryAI Endoscopy Analysis Software
Description

AI-powered real-time Barrett's Esophagus surveillance and early esophageal adenocarcinoma detection system with dynamic frame-level detection and granular mapping for dysplastic vs non-dysplastic differentiation. In development with FDA Breakthrough Device Designation.

3DovaSound
CategoryAI Ultrasound Analysis Software
Description

AI-powered intestinal ultrasound imaging analysis platform for rapid IBD activity assessment in Crohn's disease and ulcerative colitis, with automated detection, segmentation, and standardized IUS measurements aligned with IBUS/IUSCAN standards.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership13 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-07
Description

Collaboration on development and validation of DovaVision UC MES for Mayo Endoscopic Score. Joint regulatory preparation for FDA clearance. Mayo Clinic provides clinical expertise and validation data.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2025-05-01
Description

Global GI-focused CRO providing clinical trial imaging services. DovaVision UC commercially available through Alimentiv's Notō platform for Phase I-IV UC clinical trials. Partnership announced at DDW 2025 for AI-powered endoscopy analysis.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

MoU between DIGITAL and INOVAIT supporting Canadian companies including Dova. Paves way for accelerated commercialization and strengthened innovation pathways.

Strategic tierStrategicTypeGTM or Marketing Partner
Description

Canada's artificial intelligence cluster that led the Canadian delegation at VivaTech 2026 where Dova was selected as Tech for Change company.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic partnership with Dr. Simon Travis and Dr. James East for AI endoscopy validation. KOLs provide clinical expertise and research collaboration.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic partnership with Dr. Remo Panaccione and Dr. Brian Bressler for IBD research and validation.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Academic partnership with Dr. Helmut Messmann for Barrett's Esophagus AI research.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with Dr. Mike Dolinger for intestinal ultrasound AI development.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with Dr. Vipul Jairath, Chief Medical Officer at Alimentiv, for IBD clinical research.

10IBUS (International Bowel Ultrasound)
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Global KOL organization for bowel ultrasound. Dr. Kerri Novak and Dr. Mike Dolinger as co-founders of iUSCAN.

satisfai.health
Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Intestinal Ultrasound Group of the United States and Canada. Partnership for DovaSound IUS AI development.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with Dr. Douglas K. Rex, Distinguished Professor, for GI endoscopy AI validation.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Partnership with Dr. Bill Karnes for high-risk colonoscopy and esophageal disorders research.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Medtronic's GI Genius is the most widely deployed AI endoscopy platform, offering real-time polyp detection during colonoscopy. It is the primary incumbent competing with Dova's DovaVision UC for share of AI-augmented endoscopy workflows across hospitals and trials globally.

TypeDirect peer
Description

Iterative Health develops AI for gastroenterology, including IBD endoscopic scoring and clinical trial endpoints — directly overlapping DovaVision UC's use case and serving the same pharma-sponsored IBD trial market.

TypeEmerging player
Description

Virgo uses AI to automate endoscopic procedure documentation and analysis for IBD and other GI conditions, intersecting Dova's IBD scoring and clinical-trial analytics focus with a complementary workflow angle.

4Cosmo Intelligent Medical Devices
TypeEmerging player
Description

Cosmo develops AI-based GI endoscopy products including the GI Genius lineage and other GI AI tools, positioning it as an emerging competitor in the same AI-endoscopy category as Dova.

TypeBroad incumbent
Description

Overjet is an FDA-cleared dental imaging AI platform expanding across dental specialties. Its AI medical-imaging SaaS model and regulatory footprint (where Dova's VP RA/QA previously worked) make it a broader medical-imaging AI comparable.

TypeBroad incumbent
Description

Viz.ai is an established medical imaging AI company with FDA-cleared products deployed across hospital systems — comparable as a scaled, specialty-focused medical imaging AI SaaS business with regulatory maturity Dova is pursuing.

TypeBroad incumbent
Description

Aidoc provides AI-driven radiology imaging analysis deployed across hundreds of hospitals — comparable as a scaled medical imaging AI platform with enterprise SaaS distribution and multi-product FDA clearances.

TypeEmerging player
Description

Enlitic develops AI for medical imaging interpretation across modalities. Its broader imaging-AI approach and regulatory experience (where Dova's VP RA/QA previously worked) make it a comparable medical-imaging AI peer.

TypeEmerging player
Description

Aidence develops AI for medical imaging diagnostics (notably lung cancer), comparable to Dova as a specialty-focused medical imaging AI company pursuing clinical adoption and regulatory clearances.

TypeEmerging player
Description

Arterys provides cloud-based AI medical imaging platforms with multiple FDA-cleared products — comparable as a multi-product medical imaging AI SaaS business pursuing specialty clinical workflows similar to Dova's.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Satisfai Health

Medical Imaging AI Softwaresatisfai.health

Dova Health Intelligence (formerly Satisfai Health) develops AI-powered computer-vision software for gastrointestinal disease assessment, with DovaVision UC, DovaVision BE, and DovaSound serving pharmaceutical clinical trial sponsors, CROs, and gastroenterology providers through a SaaS/API platform.

What Satisfai Health does

Dova Health Intelligence (formerly Satisfai Health) is a Vancouver-based medical AI company developing computer-vision and deep-learning software for gastrointestinal disease assessment. The company builds three product lines — DovaVision UC for ulcerative colitis endoscopic severity scoring from colonoscopy videos, DovaVision BE for Barrett's Esophagus surveillance and early esophageal adenocarcinoma detection, and DovaSound for intestinal ultrasound analysis in inflammatory bowel disease — all delivered via a cloud-based API/SaaS platform with three-layered (video/frame/pixel) explainable outputs and embedded quality control. DovaVision BE holds FDA Breakthrough Device Designation (December 2023), and the company is pursuing FDA clearance for DovaVision UC in collaboration with Mayo Clinic. Its proprietary models are trained on 108 million annotated endoscopy frames and validated at 0.867 QWK and 0.869 ICC against expert central reading.

The company earns revenue through subscription-based B2B SaaS contracts for clinical trial imaging analysis, anchored by an exclusive channel partnership with Alimentiv (a GI-specialized CRO) that makes DovaVision UC commercially available on the Notō imaging platform for Phase I-IV ulcerative colitis trials. Additional revenue streams under development include FDA-cleared medical device sales for clinical practice (DovaVision BE, DovaVision UC post-clearance, and DovaSound) and enterprise licensing to pharmaceutical sponsors and academic medical centers. The customer base spans pharmaceutical/biotech trial sponsors (primary), CROs such as Alimentiv (primary), healthcare providers, and academic research institutions including Oxford, Calgary, NYU, Indiana, and UCI. To date the company has disclosed CAD $2 million in non-dilutive grant funding from Canada's DIGITAL Supercluster and acquired Docbot in November 2022; no institutional venture financing has been publicly disclosed.

Satisfai Health firmographics

Firmographics
Name
Satisfai Health
Legal name
Dova Health Intelligence Inc.
Website
https://satisfai.health
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Short description
Dova Health Intelligence (formerly Satisfai Health) develops AI-powered computer-vision software for gastrointestinal disease assessment, with DovaVision UC, DovaVision BE, and DovaSound serving pharmaceutical clinical trial sponsors, CROs, and gastroenterology providers through a SaaS/API platform.
Ownership category
akta.pro rank

Satisfai Health industry classification

Industry
Product category
Medical Imaging AI Software
NAICS
Software Publishers (513210)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLACANAG
SaMD – Imaging & Signal Analysis (AI/ML)
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
SECONDARYHLAHABAJ
Radiology AI, CAD & Advanced Visualization Software
Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment
SECONDARYHLAAALAO
Digital & AI-Enabled Diagnostics (algorithmic interpretation, decision support tied to assays)

Keywords

  • Gastrointestinal AI software
  • Endoscopy image analysis
  • Medical imaging AI
  • Ulcerative colitis diagnostics
  • Intestinal ultrasound analysis

Where Satisfai Health is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

Satisfai Health business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Clinical Trial Services - DovaVision UC: AI-powered endoscopy analysis provided to pharmaceutical companies and CROs for clinical trial endpoints. Currently available for research and clinical trials through Alimentiv partnership. B2B enterprise licensing model.
  2. SaaS Platform - API-Based Analysis: Cloud-based SaaS application for video analysis delivered via secure API integration. Subscription-based model for clinical sites, research institutions, and enterprise deployments.
  3. Medical Device Development: DovaVision BE and DovaSound in development for clinical practice. Future revenue from FDA-cleared medical devices for hospital and clinical deployment.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

Satisfai Health product offering

Product offering

Core offering

Satisfai Health, now operating as Dova Health Intelligence, develops AI-powered computer vision software that analyzes gastrointestinal medical imaging (colonoscopy, gastroscopy, and intestinal ultrasound videos) to deliver quantitative disease severity scoring for ulcerative colitis, Barrett's Esophagus, and inflammatory bowel disease. The products are delivered as cloud-based SaaS with API integration for clinical trials, pharmaceutical research, and future clinical practice.

Product overview

Dova Health Intelligence (formerly Satisfai Health) operates as a unified AI-powered platform with three core products targeting gastrointestinal care and clinical research. The product portfolio centers on DovaVision UC for ulcerative colitis endoscopic analysis, DovaVision BE for Barrett's Esophagus detection, and DovaSound for intestinal ultrasound IBD assessment. All products share a common AI infrastructure built on deep learning models trained on millions of expertly annotated medical images, delivered via secure cloud-based SaaS with embedded quality assurance and API-based integration capabilities. The platform serves both pharmaceutical companies conducting clinical trials and healthcare providers delivering patient care.

Differentiator

Problem solved

Functional benefit

Brands

  • DovaVision UC: AI-powered dynamic frame-level Mayo Endoscopic Sub-score feature analysis solution for endoscopy videos in ulcerative colitis clinical trials.
  • DovaVision BE
  • DovaSound

Products and services

  • DovaVision UC AI-powered endoscopy analysis platform providing frame-level quantitative assessments and standardized MES and UCEIS scoring outputs from colonoscopy videos for ulcerative colitis clinical trials and research.
  • DovaVision BE AI-powered real-time Barrett's Esophagus surveillance and early esophageal adenocarcinoma detection system with dynamic frame-level detection and granular mapping for dysplastic vs non-dysplastic differentiation. In development with FDA Breakthrough Device Designation.
  • DovaSound AI-powered intestinal ultrasound imaging analysis platform for rapid IBD activity assessment in Crohn's disease and ulcerative colitis, with automated detection, segmentation, and standardized IUS measurements aligned with IBUS/IUSCAN standards.

Quantifiable outcome

  • 0.867 Quadratic Weighted Kappa (QWK) for video-level MES scoring
  • +2 more outcomes

Companies that use Satisfai Health

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Satisfai Health technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature5 records

Satisfai Health partnerships and signals

Strategic signal

Partnerships

13 partnerships are on record, tiered core and strategic.

  • Mayo CliniccoreStrategic or Co-development Partner · 7 October 2025Collaboration on development and validation of DovaVision UC MES for Mayo Endoscopic Score. Joint regulatory preparation for FDA clearance. Mayo Clinic provides clinical expertise and validation data.
  • AlimentivcoreChannel Partner/ Reseller/ Distributor · 1 May 2025Global GI-focused CRO providing clinical trial imaging services. DovaVision UC commercially available through Alimentiv's Notō platform for Phase I-IV UC clinical trials. Partnership announced at DDW 2025 for AI-powered endoscopy analysis.
  • INOVAITstrategicStrategic or Co-development PartnerMoU between DIGITAL and INOVAIT supporting Canadian companies including Dova. Paves way for accelerated commercialization and strengthened innovation pathways.
  • SCALE AIstrategicGTM or Marketing PartnerCanada's artificial intelligence cluster that led the Canadian delegation at VivaTech 2026 where Dova was selected as Tech for Change company.
  • University of OxfordstrategicStrategic or Co-development PartnerAcademic partnership with Dr. Simon Travis and Dr. James East for AI endoscopy validation. KOLs provide clinical expertise and research collaboration.
  • University of CalgarystrategicStrategic or Co-development PartnerAcademic partnership with Dr. Remo Panaccione and Dr. Brian Bressler for IBD research and validation.
  • University of AugsburgstrategicStrategic or Co-development PartnerAcademic partnership with Dr. Helmut Messmann for Barrett's Esophagus AI research.
  • NYU Grossman School of MedicinestrategicStrategic or Co-development PartnerPartnership with Dr. Mike Dolinger for intestinal ultrasound AI development.
  • Western UniversitystrategicStrategic or Co-development PartnerPartnership with Dr. Vipul Jairath, Chief Medical Officer at Alimentiv, for IBD clinical research.
  • IBUS (International Bowel Ultrasound)strategicStrategic or Co-development PartnerGlobal KOL organization for bowel ultrasound. Dr. Kerri Novak and Dr. Mike Dolinger as co-founders of iUSCAN.
  • IUSCANstrategicStrategic or Co-development PartnerIntestinal Ultrasound Group of the United States and Canada. Partnership for DovaSound IUS AI development.
  • Indiana University School of MedicinestrategicStrategic or Co-development PartnerPartnership with Dr. Douglas K. Rex, Distinguished Professor, for GI endoscopy AI validation.
  • UCI (University of California Irvine)strategicStrategic or Co-development PartnerPartnership with Dr. Bill Karnes for high-risk colonoscopy and esophageal disorders research.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Satisfai Health competitors and assessment

Company assessment

Direct peers

  • Medtronic (GI Genius): Medtronic's GI Genius is the most widely deployed AI endoscopy platform, offering real-time polyp detection during colonoscopy. It is the primary incumbent competing with Dova's DovaVision UC for share of AI-augmented endoscopy workflows across hospitals and trials globally.
  • Iterative Health: Iterative Health develops AI for gastroenterology, including IBD endoscopic scoring and clinical trial endpoints — directly overlapping DovaVision UC's use case and serving the same pharma-sponsored IBD trial market.

Emerging players

  • Virgo Surgical Solutions: Virgo uses AI to automate endoscopic procedure documentation and analysis for IBD and other GI conditions, intersecting Dova's IBD scoring and clinical-trial analytics focus with a complementary workflow angle.
  • Cosmo Intelligent Medical Devices: Cosmo develops AI-based GI endoscopy products including the GI Genius lineage and other GI AI tools, positioning it as an emerging competitor in the same AI-endoscopy category as Dova.
  • Enlitic: Enlitic develops AI for medical imaging interpretation across modalities. Its broader imaging-AI approach and regulatory experience (where Dova's VP RA/QA previously worked) make it a comparable medical-imaging AI peer.
  • Aidence: Aidence develops AI for medical imaging diagnostics (notably lung cancer), comparable to Dova as a specialty-focused medical imaging AI company pursuing clinical adoption and regulatory clearances.
  • Arterys: Arterys provides cloud-based AI medical imaging platforms with multiple FDA-cleared products — comparable as a multi-product medical imaging AI SaaS business pursuing specialty clinical workflows similar to Dova's.

Broad incumbents

  • Overjet: Overjet is an FDA-cleared dental imaging AI platform expanding across dental specialties. Its AI medical-imaging SaaS model and regulatory footprint (where Dova's VP RA/QA previously worked) make it a broader medical-imaging AI comparable.
  • Viz.ai: Viz.ai is an established medical imaging AI company with FDA-cleared products deployed across hospital systems — comparable as a scaled, specialty-focused medical imaging AI SaaS business with regulatory maturity Dova is pursuing.
  • Aidoc: Aidoc provides AI-driven radiology imaging analysis deployed across hundreds of hospitals — comparable as a scaled medical imaging AI platform with enterprise SaaS distribution and multi-product FDA clearances.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Satisfai Health social profiles

Digital presence

Satisfai Health compliance and trust

Trust signal

Compliance2 records

Satisfai Health financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Satisfai Health leadership team

Management profile

Number of profiles

Profiles7 records

Satisfai Health funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Satisfai Health M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Satisfai Health

What does Satisfai Health do?

Satisfai Health, now operating as Dova Health Intelligence, develops AI-powered computer vision software that analyzes gastrointestinal medical imaging (colonoscopy, gastroscopy, and intestinal ultrasound videos) to deliver quantitative disease severity scoring for ulcerative colitis, Barrett's Esophagus, and inflammatory bowel disease. The products are delivered as cloud-based SaaS with API integration for clinical trials, pharmaceutical research, and future clinical practice.

Is Satisfai Health a public or private company?

Satisfai Health is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Satisfai Health founded?

Satisfai Health was founded in 2014. It employs 11 to 50 people.

Where is Satisfai Health based?

Satisfai Health is headquartered in Vancouver, Canada, in the North America region.

How does Satisfai Health make money?

Three revenue lines are on record. Clinical Trial Services - DovaVision UC is the primary driver. The others are saaS Platform - API-Based Analysis and medical Device Development.

Who are Satisfai Health's main competitors?

Direct peers on record are Medtronic (GI Genius) and Iterative Health. Emerging players are Virgo Surgical Solutions, Cosmo Intelligent Medical Devices, Enlitic, Aidence and Arterys. Broad incumbents are Overjet, Viz.ai and Aidoc.

Does Satisfai Health have an API?

Yes. DovaVision UC provides a secure cloud-based API for high-throughput analysis across clinical sites, multi-center studies, and global research networks. The API supports robust authentication, compliance safeguards, and streamlined interoperability. Analysis results are output as JSON data and visual overlays/video with scoring burn-ins. On average it takes about 15 minutes to analyze a procedure and output both a video overlay and JSON data.

What industry is Satisfai Health in?

Satisfai Health's product category is Medical Imaging AI Software. Its primary akta.pro industry code is HLACANAG, SaMD – Imaging & Signal Analysis (AI/ML), with a secondary code of HLAHABAJ, Radiology AI, CAD & Advanced Visualization Software. Its NAICS code is 513210 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireAlimentiv and Satisfai Health Extend Partnership to Accelerate Development of Innovative Imaging Technologies to Tackle GI Disease ChallengesAlimentiv and Satisfai Health expanded their partnership to integrate Certai, an AI scoring software for ulcerative colitis, into Alimentiv's Notō imaging platform. The software provides frame-to-video disease activity assessment for clinical trials, aiming to improve trial quality and efficiency. Alimentiv will continue investing in innovative imaging solutions.AlimentivAlimentiv and Satisfai Health Extend Partnership to Accelerate Development of Innovative Imaging Technologies to Tackle GI Disease ChallengesAlimentiv, a GI-focused CRO, announced on October 12, 2024 that it is expanding its partnership with Satisfai Health, which provides AI medical solutions for gastrointestinal diseases. The collaboration gives sponsors access to Certai, an assistive scoring software for ulcerative colitis endoscopic videos, integrated into Alimentiv's Not platform. Certai is not a medical device and is not used for clinical decision-making.PR NewswireAlimentiv y Satisfai Health anuncian la disponibilidad comercial de una innovadora herramienta de puntuaciónAlimentiv and Satisfai Health announced the commercial availability of Certai, an AI-powered tool for the automated analysis of endoscopic video in clinical trials for ulcerative colitis. The solution is exclusively available to Alimentiv's sponsor clients and integrates Satisfai's technology into Alimentiv's Notō platform to enhance data analysis in Phase I-IV trials. This partnership aims to provide advanced insights and standardized scoring for inflammatory bowel disease research.PR NewswireAlimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical TrialsAlimentiv and Satisfai Health have announced the commercial availability of Certai, an AI-powered automated scoring tool for assessing ulcerative colitis in Phase I through IV IBD clinical trials. The tool will be exclusively available through Alimentiv's multi-modal imaging platform Notō, providing standardized endoscopic video analysis alongside the company's central reading services. This partnership integrates Satisfai Health's AI technology into Alimentiv's clinical trial services, with the goal of improving data accuracy and potentially reducing trial timelines and costs for sponsor clients.PR NewswireAlimentiv et Satisfai Health annoncent la disponibilité commerciale d'un outil de notation hautement innovant basé sur l'IA pour l'évaluation de la colite ulcéreuse au cours des essais cliniques de phAlimentiv and Satisfai Health have announced the commercial availability of Certai, an AI-powered tool for analyzing endoscopic video in inflammatory bowel disease clinical trials. The tool will be exclusively available to Alimentiv's sponsor clients and integrated into their Notō multimodal imaging platform, providing advanced data insights alongside Alimentiv's central reading services. Certai was developed using comprehensive global data from anonymized IBD colonoscopy videos with clinical supervision from leading world experts in IBD evaluation and scoring.PR NewswireAlimentiv und Satisfai Health kündigen die kommerzielle Verfügbarkeit eines hochinnovativen KI-gestützten Scoring-Tools für die Beurteilung von Colitis Ulcerosa in klinischen Studien der Stadien I bisAlimentiv and Satisfai Health announced the commercial availability of Certai, an AI-powered scoring tool for assessing Ulcerative Colitis in clinical trials. The solution is exclusively available to Alimentiv's sponsor clients and integrates into Alimentiv's Notō imaging platform to provide enhanced data insights. This partnership aims to standardize disease assessment through automated secondary analysis of endoscopic videos.PR NewswireAlimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical TrialsAlimentiv and Satisfai Health announced the commercial availability of Certai, an AI-powered tool for secondary analysis of endoscopic video in IBD clinical trials. The tool is exclusively available to Alimentiv's sponsor clients and integrates into Alimentiv's Notō platform. It is not a medical device and is not used for clinical decision-making.PR NewswireAlimentiv, Satisfai Health et Virgo annoncent un partenariat visant à utiliser une technologie basée sur l'IA pour améliorer les essais cliniques dans les MII et autres maladies gastro-intestinalesAlimentiv, Satisfai Health, and Virgo have announced a strategic partnership to integrate AI-based imaging technology into clinical trials for inflammatory bowel disease (IBD) and other gastrointestinal conditions. The collaboration grants Alimentiv exclusive access to Satisfai's SmartScore central reading tool and Virgo's cloud-based video capture fleet to enhance trial efficiency and develop new assessment metrics. This initiative aims to accelerate the market entry of new therapies by improving the scalability and effectiveness of gastroenterology clinical studies.PR NewswireAlimentiv, Satisfai Health und Virgo kündigen Partnerschaft an, um KI-gesteuerte Technologie zur Verbesserung von klinischen Studien bei CED und anderen Erkrankungen des GI-Traktes zu nutzenAlimentiv, Satisfai Health und Virgo haben eine strategische Partnerschaft angekündigt, um KI-gesteuerte Technologien für klinische Studien bei chronisch-entzündlichen Darmerkrankungen (CED) und anderen Erkrankungen des Magen-Darm-Traktes einzusetzen. Die Partnerschaft kombiniert Satisfais KI-Lösungen für medizinische Bildgebungsanalysen, Virgos HIPAA- und SOC-2-konforme Cloud-Videotechnologie sowie Alimentivs 21CFR11-konforme Lösungen und Expertise im zentralen Bildmanagement. Pharma- und Biotech-Sponsoren erhalten dadurch Zugang zu neuartigen Endpunkten und skalierbaren Lösungen, um neue Therapien schneller auf den Markt zu bringen.